Clinical trial Recruiting at 1 site Interventional Ages 65 and up

Cognitive training that addresses race-based stress for older Black adults with mild cognitive impairment

Official title: Race Based Stress and Empowerment Focused Compensatory Cognitive Training for Mild Cognitive Impairment

Run by Rosalind Franklin University of Medicine and Science · NCT06330844 · Data updated 2026-11-12

This project will try adding race-based stress and empowerment sessions to a compensatory cognitive training program to see if it helps older Black adults with mild cognitive impairment.

Quick facts

Study typeInterventional
Ages65 Years and up
SexAll
Enrollment9 (estimated)
SponsorRosalind Franklin University of Medicine and Science
Academic / other
Locations1 site (Chicago, Illinois)
StatusRecruiting
StartedMarch 1, 2025
Main results expectedSeptember 15, 2027
Study endsMarch 15, 2028
Registry record updatedJuly 24, 2025
Trial IDNCT06330844 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are community-dwelling adults aged 65 or older who self-identify as Black/African American (including multi-racial identities that include Black), have mild cognitive impairment or self-reported cognitive difficulties, can travel to Rosalind Franklin University, and do not have dementia or recent significant brain injury.

Probably not a fit

Patients with a diagnosis of dementia, intellectual disability, recent concussion or moderate-to-severe traumatic brain injury, or those unable to attend in-person sessions are unlikely to benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a two-phase project adapting a Motivationally Enhanced Compensatory Cognitive Training (ME-CCT) program to include Race-Based Stress and Empowerment components (RBSEF-CCT-MCI). Phase 1 is an open pilot delivering group-based RBSEF-CCT-MCI over eight weeks to evaluate feasibility and acceptability with 8-10 participants per group. Phase 2 is a randomized controlled trial comparing the adapted RBSEF-CCT-MCI against the original ME-CCT, with participants randomized to one of the two eight-week group programs. The work focuses on older adults who self-identify as Black/African American (or multi-racial including Black) with mild cognitive impairment and requires in-person attendance at Rosalind Franklin University in Chicago.

Why it matters

Potential benefit: If successful, the adapted program could improve everyday memory, coping with stress, and slow functional decline for Black older adults with mild cognitive impairment.

How similar studies have gone: Compensatory cognitive training approaches like ME-CCT have shown promise in older adults with MCI, but integrating a race-based stress and empowerment component is a novel adaptation with limited prior testing.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* The study will be conducted in-person, so they must be able to travel to Rosalind Franklin University.
* The study will initially be limited to participants who self-identify as Black/African American, or who self-identify with other racial/ethnic groups in addition to self-identifying as Black/African-American; however, may be expanded to include participants that identify as Hispanic/Latine.

Exclusion Criteria:

* Participants are ineligible to participate in this study if they are not at least 65 years of age and are not experiencing at least mild cognitive impairment or self-reported cognitive difficulties.
* Participants will also be excluded if they have a diagnosis of dementia (i.e., major neurocognitive disorder), intellectual disability, mild head injury (i.e., concussion) within the last six months, and/or a history of moderate to severe traumatic brain injury.
* Diagnosis of dementia may be from self-report or other medical records, or for participants to fail screening cognitive assessments (i.e., the RBANS) that would suggest they may be at the level of dementia (i.e., major neurocognitive disorder) as ultimately determined by study PI with objective scores less then 2 standard deviations below the mean on the RBANS.

Where it's running

  • Rosalind Franklin University of Medicine and Science
    Chicago, Illinois, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.